Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
  Allergan Aesthetics redefines skin quality communication with launch of Skin Quality Index,   March 17, 2026
  GN Store Nord enters into agreement to sell its hearing business to Amplifon for DKK 17.0 billion,   March 17, 2026
  AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers,   March 17, 2026
  US FDA clears Unixell Biotech’s IND for allogeneic iPSC-derived cell therapy, UX-GIP001 for focal epilepsy,   March 16, 2026
  US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa,   March 16, 2026
  Luxna Biotech & Inabata ink license agreement for manufacture and sale of modified nucleic acid GuNA amidite,   March 16, 2026
  UK MHRA approves Sun Pharma’s deuruxolitinib to treat severe alopecia areata in adults,   March 13, 2026
  US FDA grants orphan drug designation to Eledon Pharma’s tegoprubart for prevention of allograft rejection in liver transplantation,   March 12, 2026
  Chiesi and Bespak partner to advance carbon minimal inhaler production with UK manufacturing site,   March 12, 2026
  Veristat expands regulatory and clinical services to Chinese drug and device companies seeking efficient way to enter European markets,   March 12, 2026
  MiNK Therapeutics collaborates with C-Further to advance PRAME-targeted iNKT cell therapy for paediatric cancer,   March 12, 2026
  WHO releases new target product profiles for urgently needed antibiotics,   March 12, 2026
  Ministerial visit to Athlone Laboratories will be a vision for future of critical medicines in Ireland,   March 11, 2026
  Medtronic to acquire Salt Lake City, Utah-based private company, Scientia Vascular for $550 million,   March 11, 2026
  Agilent to buy clinical and research pathology solutions leader, Biocare Medical for $950 million,   March 11, 2026
  China NMPA approves Harbour BioMed and Kelun-Biotech’s IND application for HBM7575/SKB575 to treat atopic dermatitis,   March 10, 2026
  METI & TSE select Chugai for the “2026 KENKO Investment for Health” for the third consecutive year,   March 10, 2026
  Heidelberg Pharma and HealthCare Royalty amend to existing royalty agreement and the participation of Soleus Capital,   March 10, 2026
  US FDA accepts and grants priority review status to AstraZeneca and Daiichi Sankyo’s sBLA for Enhertu to treat adult patients with HER2-positive early breast cancer,   March 10, 2026
  GSK and Alfasigma ink agreement on worldwide rights for linerixibat, an IBAT inhibitor for cholestatic pruritus in primary biliary cholangitis,   March 10, 2026

 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram